Information on the dilution and adulteration of copyright isn't routinely gathered in Europe. Nonetheless, based on complementary information and facts noted to your EMCDDA and data readily available from other resources, some Assessment of latest traits about pharmacologically active adulterants in copyright products in Europe may be performed.